German China India

USA: Consumer Healthcare

Pfizer Announces Strategic Restructuring of its Healthcare Businesses

| Editor: Alexander Stark

Pfizer Consumer Healthcare is one of the largest OTC health care products businesses in the world.
Pfizer Consumer Healthcare is one of the largest OTC health care products businesses in the world. (Source: Pixabay CC0)

Pfizer said that a range of options will be considered, including a full or partial separation of the Consumer Healthcare business from Pfizer through a spin-off, sale or other transaction.

New York/USA — Although the company may ultimately determine to retain the business, Pfizer is reviewing strategic alternatives for its Consumer Healthcare business.

Pfizer Consumer Healthcare is one of the largest OTC health care products businesses in the world with 2016 revenues of approximately $ 3.4 billion, operating in more than 90 countries globally. This business markets two of the ten top selling consumer healthcare brands globally — Centrum and Advil. In addition, the business has ten brands that each exceeded $ 100 million in 2016 sales, and several local brands that are top-ranked in their respective markets.

Ian Read, Pfizer Chairman and Chief Executive Officer said: “Although there is a strong connection between Consumer Healthcare and elements of our core biopharmaceutical businesses, it is also distinct enough from our core business that there is potential for its value to be more fully realized outside the company."

The company expects that any decision regarding strategic alternatives for Pfizer Consumer Healthcare would be made during 2018, adding that it does not plan to make any further statements about the strategic review process until a decision has been reached or upon the completion of the strategic review.

What the Trump Administration Means for Big Pharma’s US Perspective

USA: 500-Bio.-US$ in Pharmaceuticals?

What the Trump Administration Means for Big Pharma’s US Perspective

01/26/2017 - Despite uncertainty surrounding future healthcare policy, the US pharmaceutical market will approach $500 billion by 2020, says recent figures indicate… read...

Comments are being loaded ....

Leave a comment
  1. Avatar
    Avatar
    Edited by at
    Edited by at
    1. Avatar
      Avatar
      Edited by at
      Edited by at

Comments are being loaded ....

Report comment

Kommentar Freigeben

Der untenstehende Text wird an den Kommentator gesendet, falls dieser eine Email-hinterlegt hat.

Freigabe entfernen

Der untenstehende Text wird an den Kommentator gesendet, falls dieser eine Email-hinterlegt hat.

copyright

This article is protected by copyright. You want to use it for your own purpose? Infos can be found under www.mycontentfactory.de (ID: 44945351 / Pharma & Food)